The role of prostaglandins as mediators of the inflammatory response is still not entirely clear. Their ability to increase vascular permeability in man and animals (Crunkhorn and Willis, 1969) , and their ability to cause leucocyte emigration (Kaley and Weiner, 1971) , suggest that they may be important mediators of the acute phase of the inflammatory reaction. Significant levels of prostaglandin E2 (PGE2) and prostaglandin F2X (PGF2 0) have been recovered from inflammatory exudates (Willis, 1969) . Control of the inflammatory response, with special reference to the prostaglandins has been reviewed by Willoughby and others (1973) . The observations of Vane and his colleagues that aspirin, and other 'aspirin-like' drugs, are potent inhibitors of prostaglandin synthesis may explain the antiinflammatory action of these drugs in vivo (Vane, 1971; Flower, 1974) .
Using a radioimmunoassay technique to measure PGB levels in human synovial fluids, Levine (1973) showed that in a group of patients with inflammatory effusions the mean PGB concentration was significantly higher than that in a group with noninflammatory lesions. A group with inflammatory lesions who had received salicylate or indomethacin therapy, however, had the same mean PGB concentration as the noninflammatory group.
Furthermore, when culture fluids of human synovial tissues were analysed for prostaglandins the addition of indomethacin (5 ,ug/ml) reduced prostaglandin levels to less than 2 % of those found in both control and colchicine-stimulated cultures. A study by Higgs and others (1974) , using a bioassay technique to measure prostaglandins in rheumatoid arthritis (RA) synovial fluid, showed the average concentration in fluids from untreated patients to be seven times higher than that in fluids from patients receiving aspirin-like drugs.
The present study was designed to measure the activity of prostaglandin synthetase in rheumatoid synovium, rather than to measure endogenous prostaglandins which would be altered by surgical manipulation (Piper and Vane, 1971 The synovial microsomes were resuspended in fresh buffer mixture, and 1-9 ml aliquots were incubated with 4IC arachidonic acid* (100 nCi/0. 1 ml buffer) at 370C, for one hour, with shaking. The reaction was terminated by addition of 0 25 ml of 2 mol/l citric acid. After shaking briefly, 8 ml of liquid scintillant was added (0.5% PPO and 0.03% dimethyl POPOP in toluene) and the samples counted in a Phillips liquid scintillation system. Quench corrections were made using a channel ratio method.
CHARACTERIZATION OF FORMED PROSTAGLANDINS
The formed 14C prostaglandins were characterized by running in various chromatographic systems with authentic prostaglandin standards, by chemical conversion to other prostaglandins followed by further chromatographic identification, and by bioassay of TLC eluates. The chromatographic systems used were: (1) system AI, with and without silver nitrate; (2) system AII, with silver nitrate; (3) chloroform/methanol/acetic acid/water (90:6:1:0.75).
Prostaglandin E2 was further identified by: (1) conversion to PGB2 with sodium hydroxide followed by chromatographic characterization in system AI; (2) conversion with sodium borohydride into equal amounts of PGF20C and PGF2[ followed by chromatographic characterization in system Al.
The possibility that the microsomal preparation might contain prostaglandin-metabolizing activity was investigated by adding 3H-PGE2 and 3H-PGF2(x as substrate, in place of 14C arachidonic acid, to separate microsomal incubates. These were then taken through exactly the same incubation, extraction, and separation procedures as for the arachidonate incubates.
BIOASSAY OF TLC ELUATES
A portion of the chloroform/methanol extract was applied to a TLC plate (silica gel G, 0*25 mm) and developed for 15 cm in the Al solvent system. 1 cm bands were eluted with methanol (1 *2 ml), an aliquot of which (0.2 ml) was used to measure the radioactivity present. The remainder was evaporated under nitrogen at 400, redissolved in Tyrode solution (1.0 ml) and aliquots (0-1 ml) used for bioassay.
A rat stomach strip was superfused with Tyrode's solution containing a mixture of antagonists (Gilmore, Vane, and Wyllie, 1968) . Standard solutions of PGE2 and PGF2OC were used for calibration.
PROTEIN ESTIMATION
Microsomal protein concentration was measured by the method of Lowry and others (1951) , using bovine serum albumin as standard. Concentrations varied between experiments but were in the range of 0*4-2 0 O mg/ml.
Results
The microsomal preparation from human rheumatoid synovial tissue was found to be capable of producing significant metabolism of added 14C arachidonic acid. The chromatographic separation of one such incubate is shown in Fig. 1 other peaks of radioactivity were detected. This suggests that under the incubation conditions described the microsomal preparation from human rheumatoid synovial tissue contains no prostaglandin metabolizing activity. When the fifteen 1 cm band eluates were each bioassayed for their prostaglandin activity as described, a single major peak of activity was found which corresponded to the radioactive peak designated PGE2, and was coincident with standard PGE2 run in parallel. A small amount of activity was seen in the PGF20c region but no other significant peaks of activity were found. Combined chromatographic, chemical, and bioassay results thus strongly support the original tentative designations of the products of arachidonic acid metabolism as PGE2 and PGF2X . Addition of low concentrations of several 'aspirinlike' drugs to active microsomal preparations in vitro (i.e. those derived from patients taking indomethacin, ibuprofen, or naproxen) produced a dose-related inhibition of prostaglandin synthesis. Fig. 3 shows a composite dose response curve to aspirin derived from four consecutive preparations. On each occasion when inhibition by other 'aspirinlike' drugs was studied in vitro aspirin was also assayed on the same preparation as a standard compound, and the concentration of drug necessary to produce 50 % inhibition of PGE2 synthesis (IC50) calculated graphically from the dose response curve obtained. Drug potencies expressed on a molar basis relative to aspirin are shown in Table II (Crook and Collins, 1975) . When several aspirin-like drugs were tested in vitro for their ability to inhibit prostaglandin synthesis, a wide range of potencies was found. Paracetamol, a drug with no anti-inflammatory activity, was virtually inactive in our assay, though reported to be more active than aspirin in some animal tissues (Flower and Vane, 1974) . However, salicylic acid, which is equipotent with aspirin as an antirheumatic and anti-inflammatory agent in vivo, was also virtually inactive in vitro in our assay, in agreement with the findings in other assay systems (Vane, 1971; Willis and others, 1972) . This apparent discrepancy has been discussed in detail by Smith, Ford-Hutchinson, and Elliott (1975) When indomethacin and the other drugs that apparently did not irreversibly inhibit the synthetase in vivo were tested in an in vitro system, all these 'aspirin-like' drugs were more potent inhibitors of the enzyme system than aspirin itself (Table II) .
These findings may be explained if the inhibition of the PG synthetase system by aspirin in vivo is considered to be of a noncompetitive (irreversible) type, while the in vivo inhibition caused by indomethacin and the other 'aspirin-like' drugs used here is considered to be competitive (reversible). In this latter case the manipulation of the synovial tissue through the preparative stages described may have removed these drugs from an enzyme(s) receptor site, allowing an in vitro activity of the enzyme(s). It may be that such a kinetic situation exists when the drugs are given therapeutically.
It is known that in some systems indomethacin in vitro irreversibly inhibits PG synthetase; for example the enzyme derived from sheep seminal vesicle microsomes (Smith and Lands, 1971; Raz, Stern, and Kenig-Wakshal, 1973) . However, in a bovine brain microsomal preparation Ku and Wasvary (1974) found the inhibition by indomethacin to be reversible. The PG synthetase system in human rheumatoid synovium appears to be similar to the synthetase system in human platelets, where the inhibitory effect of indomethacin in vivo on prostaglandin production and platelet aggregation is short lived compared with aspirin, which produces irreversible inhibition (Kocsis and others, 1973) . Furthermore, the use of [3H-acetyl] aspirin (Roth and Majerus, 1975) has shown that aspirin produces an irreversible acetylation of a human platelet particulate fraction protein in vivo and in vitro. The time course of action of synovial PG synthetase inhibition by aspirin might well be studied by withdrawal of the drug at varying times before synovectomy.
The finding that PG synthetase was inactive in the tissue preparation from 3 patients taking only 600 mg aspirin per day supports the view of Smith and others (1975) that the anti-inflammatory efficacy of aspirin may have important components other than its well-documented inhibition of prostaglandin synthesis. Kinetic studies are now in progress to further elucidate the nature of the inhibition of synovial PG synthetase produced by aspirin and indomethacin.
